Table 3

Univariate and multivariate analysis of longitudinal parameters of LV function to CMR derived clinical and prognostic markers

	MAPSE (septal) p value		MAPSE (lateral) p value		MAPSE (averaged) p value (β)
	UV	MV	UV	MV	UV	MV
Demographics
Age	0.36		0.11		0.13
Sex	0.27		0.44		0.74
Smoking history	0.79		0.86		0.77
Hypertension	0.64		0.65		0.94
Hypercholesterolemia	0.81		0.69		0.95
Diabetes mellitus	0.002	0.006	0.60		0.01	0.05
CK	0.26		0.72		0.33
Pain-balloon time	0.0	0.004	0.26		0.45
CMR parameters
Anterior infarct	0.33		0.91		0.54
LVEDVi	0.95		0.97		0.98
SVi	0.06	0.187	0.27		0.06	0.207
Ejection fraction	0.02	0.246	0.09	0.82	0.01	0.293
Infarct mass	0.11		0.49		0.48
Infarct volume	0.69		0.23		0.35
MVO	0.002	0.415	0.001	0.36	<0.01 (−0.57)	0.229
IMH	<0.01	<0.01	<0.01	<0.01	<0.01 (−0.65)	<0.001

CK, creatine kinase; CMR, cardiovascular MR; IMH, intramyocardial haemorrhage; LV EDVi, left ventricular end diastolic volume (indexed); MAPSE, mitral annular plane systolic excursion; MV, multivariate; MVO, microvascular obstruction; SVi, systolic volume (indexed); UN, univariate.